These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19330187)

  • 1. Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT.
    Bertagna F; Sobic-Saranovic D; Obradovic V; Artiko V; Giubbini R; Alavi A
    Hell J Nucl Med; 2009; 12(1):63. PubMed ID: 19330187
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour thrombus from follicular thyroid cancer detected by 18F-FDG-PET/CT.
    Ozülker T; Ozülker F; Eker O; Ozpaçaci T; Ozcan D
    Hell J Nucl Med; 2009; 12(1):66-7. PubMed ID: 19330189
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
    Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S
    Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
    Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
    Ramos CD; Massumoto CM; Rosa MF; Mazo-Ruiz MF; Mitteldorf C; Etchebehere EC; Santos AO; Lima MC; Cerri GG; Camargo EE
    Clin Nucl Med; 2007 Apr; 32(4):295-6. PubMed ID: 17413577
    [No Abstract]   [Full Text] [Related]  

  • 9. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult prolactinoma diagnosed by FDG PET/CT.
    Gemmel F; Balink H; Collins J; Oomen P
    Clin Nucl Med; 2010 Apr; 35(4):269-70. PubMed ID: 20305420
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidental inflammatory findings in nerves and in patients with neoplastic diseases evaluated by 18F-FDG-PET/CT.
    Bertagna F; Giubbini R; Biasiotto G; Rosenbaum J; Alavi A
    Hell J Nucl Med; 2009; 12(3):279-80. PubMed ID: 19936345
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of thyroid plasmacytoma by F-18 FDG PET/CT imaging.
    Ozkan E; Tokmak E; Kir KM
    Clin Nucl Med; 2008 Apr; 33(4):292-3. PubMed ID: 18356675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET/CT in myelofibrosis.
    Behrendt FF; Krohn T; Palmowski M; Mottaghy FM
    Nuklearmedizin; 2011; 50(6):N66-7. PubMed ID: 22138707
    [No Abstract]   [Full Text] [Related]  

  • 15. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
    Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
    Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolapsed endometrial cancer: FDG PET/CT findings.
    Kaneta T; Hakamatsuka T; Yamada T; Sato A; Higano S; Fukuda H; Takahashi S; Yamada S
    Clin Nucl Med; 2006 Mar; 31(3):180. PubMed ID: 16495748
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma.
    Thambugala GM; Fulham MJ; Mohamed A
    Australas Radiol; 2007 Oct; 51 Spec No.():B45-7. PubMed ID: 17875156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET-CT findings in epiploic appendagitis.
    Purandare NC; Dua S; Shah S; Gupta K; Sharma AR; Rangarajan V
    Clin Nucl Med; 2009 Dec; 34(12):906-8. PubMed ID: 20139829
    [No Abstract]   [Full Text] [Related]  

  • 19. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
    Lin EC
    Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous adenocarcinoma of the appendix demonstrated on F-18 FDG PET/CT.
    Lu SJ; Osmany S; Khoo JB; Ng DC
    Clin Nucl Med; 2010 Apr; 35(4):256-7. PubMed ID: 20305414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.